Patients with gastrointestinal conditions, absorption disorders, or post-bariatric surgery may not be ideal candidates for oral formulations
NiPNohHParkGShaoZGuanYParkJet al
These figures are provided for informational and research reference purposes only and do not constitute dosing advice for humans
Small-scale clinical trials revealed that GLP-1 and GLP-1-based medicines may have positive effects on low-grade inflammation, blood pressure, cholesterol, and microcirculation ( Due to their various modes of action, which include vasodilation, natriuresis, glucose and weight control, and direct cardioprotective effects, GLP-1 receptor agonists have therapeutic potential for treatment of heart failure ( Obesity is a major cause of cardiovascular diseases
Fatty Liver Disease: Excess fat accumulation in the liver, known as non-alcoholic fatty liver disease (NAFLD), is commonly associated with obesity and metabolic syndrome